dc.contributorHospital de Olhos de Araraquara
dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:22:04Z
dc.date.available2014-05-27T11:22:04Z
dc.date.created2014-05-27T11:22:04Z
dc.date.issued2006-12-01
dc.identifierArchivos de la Sociedad Espanola de Oftalmologia, v. 81, n. 12, p. 675-682, 2006.
dc.identifier0365-6691
dc.identifierhttp://hdl.handle.net/11449/69315
dc.identifier10.4321/S0365-66912006001200002
dc.identifierS0365-66912006001200002
dc.identifier2-s2.0-34248214266
dc.identifierS0365-66912006001200002.pdf
dc.identifier9114495952533044
dc.languagespa
dc.languageeng
dc.relationArchivos de la Sociedad Espanola de Oftalmologia
dc.relation0,208
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectantiinflammatory agent
dc.subjectglycolic acid derivative
dc.subjectmicrosphere
dc.subjectpoly (lactic co glycolic acid)
dc.subjectpoly (lactic-co-glycolic acid)
dc.subjecttriamcinolone acetonide
dc.subjectunclassified drug
dc.subjectdelayed release formulation
dc.subjectdiabetes mellitus
dc.subjectdrug screening
dc.subjecteditorial
dc.subjecthuman
dc.subjectinjection
dc.subjectpilot study
dc.subjectretina macula cystoid edema
dc.subjectvitreous body
dc.subjectAnti-Inflammatory Agents
dc.subjectDelayed-Action Preparations
dc.subjectDiabetes Complications
dc.subjectDrug Evaluation
dc.subjectGlycolates
dc.subjectHumans
dc.subjectInjections
dc.subjectMacular Edema, Cystoid
dc.subjectMicrospheres
dc.subjectPilot Projects
dc.subjectTriamcinolone Acetonide
dc.subjectVitreous Body
dc.titleSistema intravítreo bioerudivel de liberación prolongada de microesferas de triamcinolona (RETAAC). Comunicación preliminar de su utilidad potencial para el tratamiento del edema macular diabético
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución